alliances
The THEW Initiative aims at promoting cross-fertilization of scientific knowledge, resources and ideas that will advance the field of quantitative electrocardiography, the THEW will strive to:
- Facilitate scientific projects toward the development, testing and validation of ECG-related technologies and platforms;
- Leverage expertise and resources toward the implementation of collaborative projects among FDA, UR, and other public and private stakeholders;
- As appropriate, incorporate scientific findings from the THEW into the premarket evaluation process for electrocardiographic devices and associated methodologies, and into the total product life cycle.
Today, the THEW project is supported by numerous organizations including ECG equipment companies, contract research organizations (CROs), academic group, individuals and professional societies.
We provide below the list of organizations that have collaborated with our initiative in terms of data, technologies, resources, or data sharing (Contribution). These collaborations have led to the development and the success of this initiative.
Company |
Contribution |
Press Releases | Donation |
|---|---|---|---|
 |
|
||
|
|||
|
|||
|
|
||
|
|
||
|
|
||
|
|||
|
|
||
|
|||
|
The THEW Founding Companies are described below. These companies have contributed to the warehouse design and building through generous contributions.
[11/01/2008] Striving to advance the field of cardiac safety, the THEW initiative is developed for facilitating collaborative discussions between THEW members, and for leveraging resources to implement joint projects among FDA, University of Rochester (UR), and other public and private stakeholders. The THEW is led by individuals from the UR, the Commissioner Office of the FDA, the Center for Drug Evaluation and Research, and the Center for Devices and Radiological Health. More...
[05/27/2008] Dr. Janet Woodcock (Director, CDER-FDA) and Dr. Norman Stockbridge (Acting Director for the Division of Cardiovascular and Renal Products, CDER-FDA) signed a Letter of Agreement officially starting the partnership between the FDA and University of Rochester for the THEW initiative. More...